Copies of letters sent to healthcare professionals in May 2013, to inform of new safety information and advice

Date sent Medicine Safety information

13 May 2013

Protelos (Strontium ranelate)PDF file (opens in new window) (79Kb)

Restricted indications, new contraindications, and warnings relating to cardiovascular risks

15 May 2013

Avastin (Bevacizumab)PDF file (opens in new window) (348Kb)

Cases of necrotising fasciitis, including fatal outcomes

20 May 2013

Samsca (Tolvaptan)PDF file (opens in new window) (159Kb)

Risk of liver injury (seen at high dose in an unlicensed indication)



Posted on the UK MHRA website on 30 May 2013